SCHEMBL973623

SCHEMBL973623

CCc1cc(N(C(O)CC)C(O)CC)ccc1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7601521 0.78 SLC16A3 (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7877999 0.78 GABRP (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL41899 0.78 SLC16A3 (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7586557 0.77 KMT2A (0.42) GABRPGABRDGABRA1GABRB1GABRG2
Ammonia Solution, Strong SCHEMBL4440047 0.77 SLC16A3 (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1814072 0.77 MEN1 (0.57) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3619964 0.75 ALDH1A1 (0.47) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL24510418 0.73 GABRP (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7142490 0.73 GABRP (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9249843 0.73 SLC16A3 (0.40) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3600224-B1 SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2026-05-06 EP claimed
EP-4061326-B1 PERSONAL CARE COMPOSITION COMPRISING A MULTISTAGE POLYMER DOW GLOBAL TECHNOLOGIES LLC (US) 2026-02-25 EP claimed
EP-4093514-B1 AQUEOUS SUNCASE FORMULATION BASED ON SULFATED A CRYSTALLINE CELLULOSE SPF BOOSTER DOW GLOBAL TECHNOLOGIES LLC (US) 2025-08-06 EP claimed
US-12214067-B2 Oil-in-water emulsion sunscreen composition ISP INVESTMENTS INC. (US) 2025-02-04 US claimed
EP-3894017-B1 POLYMER BLEND FOR PERSONAL CARE FORMULATION DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-28 EP claimed
EP-3893836-B1 PERSONAL CARE FORMULATION COMPRISING A MULTISTAGE POLYMER WITH A CARBOSILOXANE DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-28 EP claimed
US-20220387290-A1 SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-12-08 US claimed
US-20220125701-A1 SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-04-28 US claimed
EP-3946642-A1 SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF ISP Investments LLC (US) 2022-02-09 EP claimed
US-20210338539-A1 LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC 2021-11-04 US claimed
EP-2379625-B1 UV AND LIGHT PROTECTIVE FILM HUHTAMAKI FORCHHEIM (DE) 2013-02-20 EP claimed
US-20110262531-A1 NANOPARTICULATE SYSTEM, PROCESS FOR THE PREPARATION OF THE SAME, USE OF THE SAME, PHOTOPROTECTIVE COMPOSITION, PROCESS FOR THE PREPARATION OF THE SAME, METHOD OF PREVENTION OF DISEASES OF THE SKIN UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL-UFRGE (BR) 2011-10-27 US claimed
EP-2379625-A1 UV AND LIGHT PROTECTIVE FILM Huhtamaki Forchheim Zweigniederlassung der Huhtamaki Deutschland GmbH & Co. KG (DE) 2011-10-26 EP claimed
EP-2344119-A2 NANOPARTICLE SYSTEM COMPRISING OIL AND UV FILTER Biolab Sanus Farmacéutica Ltda (BR) 2011-07-20 EP claimed
US-20110020251-A1 Ultraviolet-Absorbing Compounds AVOCA LLC 2011-01-27 US claimed
EP-2274324-A1 SUBSTANCES AND COMPOSITIONS FOR ENHANCING DNA REPAIR AND METHODS OF USE Cornell University (US) 2011-01-19 EP claimed
WO-2010075946-A1 UV AND LIGHT PROTECTIVE FILM HUHTAMAKI FORCHHEIM, ZWEIGNIEDERLASSUNG DER HUHTAMAKI DEUTSCHLAND GMBH & CO. KG (DE) 2010-07-08 WO claimed
EP-1092421-B1 Method for preparing ultraviolet radiation absorbing compositions ROHM & HAAS (US) 2007-03-21 EP claimed
EP-0761201-B1 Ultraviolet radiation absorption composition ROHM & HAAS (US) 2002-01-09 EP claimed
EP-0501714-B1 Cationic compositions for skin UNILEVER PLC (GB) 1997-05-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110020251-A1 Ultraviolet-Absorbing Compounds UFM1, UHRF1, CUTA GABRP 4157/4885GABRD 3461/4885GABRA1 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.